1. International Agency for Research on Cancer: GLOBOCAN 2012 Estimated cancer incidence, mortality and prevalence worldwide in 2012. 2012.
http://globocan.iarc.fr/Pages/fact_sheets_population.aspx
. Accessed 15 Jan 2015.
2. National Cancer Center, information cancer: Monitoring of Cancer Incidence in Japan. 2010.
http://ganjoho.jp/en/professional/statistics/table_download.html
. Accessed 15 Jan 2015.
3. Ministry of Health, Labour and Welfare, Statistics and Information Department: Vital statistics in 2013 (in Japanese). 2013.
http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei13/dl/00_all.pdf
. Accessed 15 Jan 2015.
4. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomised GERCOR study. J Clin Oncol. 2004;22(2):229–37.
5. Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008;26(12):2013–9.